[ET Net News Agency, 9 September 2021] KINTOR PHARMA-B (09939) fell 10.29% to HK$70.6,
dipping below the 20-D SMA of HK$73.545.
It hits an intra-day low of HK$70.6, and an intra-day high of HK$80.05. The total shares
traded was 4.22 million, with a value of HK$308.55m. The active buy/sell ratio is 48:52,
with net selling turnover of HK$9.99m. MERRILL LYNCH FE accounts for greatest net
responsive buying turnover of HK$11.56m, with volume weighted average price of HK$73.427.
CLSA LTD accounts for greatest net responsive selling turnover of HK$28.47m, with volume
weighted average price of HK$72.44. The stock has fallen a combined 15.5% over the past 2
consecutive trading days.
The Hang Seng Index now fell 575 points, or 2.19% to 25,745; the Hang Seng China
Enterprises Index now fell 253 points, or 2.68% to 9,195; the Hang Seng TECH Index now
fell 273 points, or 3.98% to 6,597; with an overall turnover of HK$136.42b.
The SSE Composite Index now rose 17 points, or 0.49% to 3,693, with an overall turnover
of RMB679.47b.
The SZSE Component Index now rose 10 points, or 0.07% to 14,698, with an overall
turnover of RMB363.31b.
Basic Information
-------------------------------------------
Nominal 70.600 % Chg -10.29%
High 80.050 Low 70.600
Shares Tr 4.22m Turnover 308.55m
10-D SMA 78.315 %H.V 72.975
20-D SMA 73.545 VWAP 73.184
50-D SMA 70.276 RSI14 46.288
-------------------------------------------
Status: Dipping below the 20-D SMA, active buy/sell ratio is 48:52, with net selling
turnover of HK$9.99m, falling a combined 15.5% over the past 2 consecutive
trading days
Table: Performance of stocks in the same sector or of relevance
Stock (Code) Price(HK$) Change(%)
-------------------------------------------------
KINTOR PHARMA-B (09939) 70.60 -10.29
GENSCRIPT BIO (01548) 35.95 -2.18
INNOVENT BIO (01801) 60.75 -5.08
JW THERAP-B (02126) 23.65 +3.96
WUXI BIO (02269) 119.90 -1.72
TIGERMED (03347) 154.00 +3.43
BEIGENE (06160) 204.80 -2.20
CANSINOBIO-B (06185) 298.00 -1.91
AKESO-B (09926) 42.50 -5.35
ALPHAMAB-B (09966) 23.10 +2.90
-------------------------------------------------
(ed)